Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FuturHealth vs Premium Health

FuturHealth
Graded #215

Higher grade

vs+0.5999999999999943
Premium Health
Graded #228

Lower grade

The verdict

FuturHealth takes it — 65.6/100 to 65/100, but only just.

FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Premium Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFuturHealth +9
60
51
Dose & formulationFuturHealth +9
81
72
Clinical oversightPremium Health +19
67
86
Labs & monitoringFuturHealth +8
61
53
FulfillmentPremium Health +7
62
69
Contract termsEven
55
55
FuturHealth · left barPremium Health · right bar

The numbers

MetricFuturHealthPremium Health
WeighScore65.6/10065/100
GradeCC
Scorecard rank#215#228
Semaglutide$199/mo (compounded)$275/mo (all doses, compounded)
TirzepatideNot disclosed$445/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
FuturHealth

Graded #215 · C

Strengths

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths

Where it loses points

  • Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received — confirm cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Pricing not shown until after the qualification questionnaire or portal login
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Premium Health

Graded #228 · C

Strengths

  • All-inclusive membership covers medication, supplies, shipping, and provider visits
  • LegitScript certified with verification seal
  • Names three licensed pharmacy partners (Hallandale, Red Rock, Strive)
  • Compounded with Vitamin B12 or B6 to aid tolerance
  • Free consultation and HIPAA-compliant telehealth via Doxy.me

Where it loses points

  • Compounded medications are not FDA-approved
  • Higher base pricing than many compounded competitors ($275/$445)
  • High-dose tiers cost extra ($100-$150/mo)
  • States available not specified on site
  • Cash-pay only; no insurance noted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard